Since a soluble form of CA-IX has been detected in the sera of patients with different cancer types and in the cell culture media [49,50,51,52], concentration-dependent binding of the antibody to recombinant soluble CA-IX was confirmed using the same SPR-Biacore setup (Figure 4B). This evidence concerns the gene CA9 and cancer.